 | This article needs additional citations for verification. (March 2008) |
 | |
| Company type | Public |
|---|---|
| Nasdaq: MAXY | |
| Industry | industrial biotechnology, pharmaceuticals |
| Founded | 1997 |
| Defunct | 2013 |
| Headquarters | Redwood City, California |
Key people | Russell J. Howard (CEO) Alejandro Zaffaroni Willem P.C. Stemmer Isaac Stein |
| Website | www.maxygen.com |
Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.[1] The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA.
- ^ "The Birth of Supergenes". The Manhattan Mercury. Manhattan, Kansas. New York Times News Service. 29 November 1998. pp. C6. Retrieved 4 November 2022 – via Newspapers.com.